Combined enrichment of neuromelanin granules and synaptosomes from human substantia nigra pars compacta tissue for proteomic analysis. 2013

S Plum, and S Helling, and C Theiss, and R E P Leite, and C May, and W Jacob-Filho, and M Eisenacher, and K Kuhlmann, and H E Meyer, and P Riederer, and L T Grinberg, and M Gerlach, and K Marcus
Department of Functional Proteomics, Medizinisches Proteom-Center, Ruhr-Universität Bochum, Bochum, Germany.

This article gives a detailed description of a protocol using density gradient centrifugation for the enrichment of neuromelanin granules and synaptosomes from low amounts (≥0.15g) of human substantia nigra pars compacta tissue. This has a great advantage compared to already existing methods as it allows for the first time (i) a combined enrichment of neuromelanin granules and synaptosomes and (ii) just minimal amounts of tissue necessary to enable donor specific analysis. Individual specimens were classified as control or diseased according to clinical evaluation and neuropathological examination. For the enrichment of synaptosomes and neuromelanin granules from the same tissue sample density gradient centrifugations using Percoll® and Iodixanol were performed. The purity of resulting fractions was checked by transmission electron microscopy. We were able to establish a reproducible and easy to handle protocol combining two different density gradient centrifugations: using an Iodixanol gradient neuromelanin granules were enriched and in parallel, from the same sample, a fraction of synaptosomes with high purity using a Percoll® gradient was obtained. Our subfractionation strategy will enable a subsequent in depth proteomic characterization of neurodegenerative processes in the substantia nigra pars compacta in patients with Parkinson's disease and dementia with Lewy bodies compared to appropriate controls. CONCLUSIONS Key features of Parkinson's disease are the degeneration of dopaminergic neurons in the substantia nigra pars compacta, an associated loss of the brain pigment neuromelanin and a resulting impairment of the neuronal network. The accumulation of iron binding neuromelanin granules is age- and disease-dependent and disease specific alterations could affect the neuronal iron homeostasis leading to oxidative stress induced cell death. The focus of the described method is the analysis of neuromelanin granules as well as axonal cell-endings of nerve cells (synaptosomes) of individual donors (control and diseased). It is the basis for the identification of disease-relevant changes in the iron homeostasis and the generation of new insight into altered protein compositions or regulations which might lead to disturbed communications between nerve cells resulting in pathogenic processes.

UI MeSH Term Description Entries
D008297 Male Males
D008543 Melanins Insoluble polymers of TYROSINE derivatives found in and causing darkness in skin (SKIN PIGMENTATION), hair, and feathers providing protection against SUNBURN induced by SUNLIGHT. CAROTENES contribute yellow and red coloration. Allomelanins,Melanin,Phaeomelanins
D002499 Centrifugation, Density Gradient Separation of particles according to density by employing a gradient of varying densities. At equilibrium each particle settles in the gradient at a point equal to its density. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Centrifugations, Density Gradient,Density Gradient Centrifugation,Density Gradient Centrifugations,Gradient Centrifugation, Density,Gradient Centrifugations, Density
D003594 Cytoplasmic Granules Condensed areas of cellular material that may be bounded by a membrane. Cytoplasmic Granule,Granule, Cytoplasmic,Granules, Cytoplasmic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013378 Substantia Nigra The black substance in the ventral midbrain or the nucleus of cells containing the black substance. These cells produce DOPAMINE, an important neurotransmitter in regulation of the sensorimotor system and mood. The dark colored MELANIN is a by-product of dopamine synthesis. Nigra, Substantia,Nigras, Substantia,Substantia Nigras
D013574 Synaptosomes Pinched-off nerve endings and their contents of vesicles and cytoplasm together with the attached subsynaptic area of the membrane of the post-synaptic cell. They are largely artificial structures produced by fractionation after selective centrifugation of nervous tissue homogenates. Synaptosome
D019636 Neurodegenerative Diseases Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures. Degenerative Diseases, Nervous System,Degenerative Diseases, Central Nervous System,Degenerative Diseases, Neurologic,Degenerative Diseases, Spinal Cord,Degenerative Neurologic Diseases,Degenerative Neurologic Disorders,Nervous System Degenerative Diseases,Neurodegenerative Disorders,Neurologic Degenerative Conditions,Neurologic Degenerative Diseases,Neurologic Diseases, Degenerative,Degenerative Condition, Neurologic,Degenerative Conditions, Neurologic,Degenerative Neurologic Disease,Degenerative Neurologic Disorder,Neurodegenerative Disease,Neurodegenerative Disorder,Neurologic Degenerative Condition,Neurologic Degenerative Disease,Neurologic Disease, Degenerative,Neurologic Disorder, Degenerative,Neurologic Disorders, Degenerative
D040901 Proteomics The systematic study of the complete complement of proteins (PROTEOME) of organisms. Peptidomics

Related Publications

S Plum, and S Helling, and C Theiss, and R E P Leite, and C May, and W Jacob-Filho, and M Eisenacher, and K Kuhlmann, and H E Meyer, and P Riederer, and L T Grinberg, and M Gerlach, and K Marcus
November 2016, Scientific reports,
S Plum, and S Helling, and C Theiss, and R E P Leite, and C May, and W Jacob-Filho, and M Eisenacher, and K Kuhlmann, and H E Meyer, and P Riederer, and L T Grinberg, and M Gerlach, and K Marcus
May 2020, NeuroImage,
S Plum, and S Helling, and C Theiss, and R E P Leite, and C May, and W Jacob-Filho, and M Eisenacher, and K Kuhlmann, and H E Meyer, and P Riederer, and L T Grinberg, and M Gerlach, and K Marcus
June 1986, Neuroscience letters,
S Plum, and S Helling, and C Theiss, and R E P Leite, and C May, and W Jacob-Filho, and M Eisenacher, and K Kuhlmann, and H E Meyer, and P Riederer, and L T Grinberg, and M Gerlach, and K Marcus
November 2006, The Journal of neuroscience : the official journal of the Society for Neuroscience,
S Plum, and S Helling, and C Theiss, and R E P Leite, and C May, and W Jacob-Filho, and M Eisenacher, and K Kuhlmann, and H E Meyer, and P Riederer, and L T Grinberg, and M Gerlach, and K Marcus
October 2022, Journal of neural transmission (Vienna, Austria : 1996),
S Plum, and S Helling, and C Theiss, and R E P Leite, and C May, and W Jacob-Filho, and M Eisenacher, and K Kuhlmann, and H E Meyer, and P Riederer, and L T Grinberg, and M Gerlach, and K Marcus
January 1989, Experimental brain research,
S Plum, and S Helling, and C Theiss, and R E P Leite, and C May, and W Jacob-Filho, and M Eisenacher, and K Kuhlmann, and H E Meyer, and P Riederer, and L T Grinberg, and M Gerlach, and K Marcus
July 1973, Science (New York, N.Y.),
S Plum, and S Helling, and C Theiss, and R E P Leite, and C May, and W Jacob-Filho, and M Eisenacher, and K Kuhlmann, and H E Meyer, and P Riederer, and L T Grinberg, and M Gerlach, and K Marcus
December 2006, Behavioral neuroscience,
S Plum, and S Helling, and C Theiss, and R E P Leite, and C May, and W Jacob-Filho, and M Eisenacher, and K Kuhlmann, and H E Meyer, and P Riederer, and L T Grinberg, and M Gerlach, and K Marcus
January 1991, Neuroscience,
S Plum, and S Helling, and C Theiss, and R E P Leite, and C May, and W Jacob-Filho, and M Eisenacher, and K Kuhlmann, and H E Meyer, and P Riederer, and L T Grinberg, and M Gerlach, and K Marcus
January 1982, Advances in neurology,
Copied contents to your clipboard!